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Abstract
Hydroxytyrosol has various pharmacological properties, including anti-oxidative stress and anti-inflammatory activities, prevent-
ing hyperglycemia, insulin resistance, and the metabolic syndrome. The present study is focused on the anti-adipogenic and
lipolytic activity of hydroxytyrosol on primary human visceral adipocytes. Pre-adipocytes were analyzed after 10 (P10) and 20 (P20)
days of treatment during differentiation and after 7 (A7) days of treatment when they reached mature shape. The treatment with
hydroxytyrosol extract significantly (P< 0.001) increased apoptosis in P10 and P20 cells in comparison to control and A7 cells;
significantly (P< 0.001) reduced triglyceride accumulation in P20 cells compared to P10 and control cells; and significantly
(P< 0.001) increased lipolysis in P20 cells in comparison to control cells and A7 mature adipocytes. Hydroxytyrosol-treated
P20 cells significantly (P< 0.05) increased expression of genes involved in inhibition of adipogenesis, such as GATA2, GATA3,
WNT3A, SFRP5, HES1, and SIRT1. In contrast, genes involved in promoting adipogenesis such as LEP, FGF1, CCND1, and
SREBF1 were significantly down-regulated by hydroxytyrosol treatment. These data suggest that hydroxytyrosol promotes lip-
olysis and apoptotic activity in primary human visceral pre-adipocytes during differentiation and does not affect already mature
adipocytes.
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Introduction
Mediterranean diet is known to promote health benefits that
partially originate from virgin olive oil, an important com-
ponent of this diet. One of the most potent phenolic com-
pounds with antioxidant activity present in olive oil is
hydroxytyrosol (HT).1 HT presents anti-inflammatory,
anti-thrombotic, and anti-atherogenic properties, improv-
ing endothelial dysfunction, hemostatic and lipid profiles,
and decreasing oxidative stress and inflammatory cell acti-
vation.2–4 This hydrosoluble and liposoluble molecule is
present either as simple phenol or esterified with elenolic
acid to form oleuropein aglycone.5
Recently, studies are focused more on functional com-
pounds of plant origin that promote suppression of differ-
entiation of preadipocytes into adipocytes or enhance
lipolysis of already mature adipocytes. For example, carno-
sic acid from rosmarin6,7 and rosavines from Rhodiola rosea8
inhibit triglyceride accumulation and stimulate lipolytic
activity in differentiating preadipocytes through a modula-
tion of genes involved in adipogenesis. There is enough
scientific evidence that HT is beneficial in treating hypergly-
cemia, insulin resistance, and the metabolic syndrome.9–11
Its metabolic and anti-inflammatory effect has been recently
reported in human Simpson–Golabi–Behmel syndrome
(SGBS) preadipocyte cell strain and in 3T3-L1 mouse
embryo fibroblasts. It was demonstrated that in both cell
model systems, the health-promoting effects of HT
were achieved via prevention of adiponectin down-
regulation in inflamed adipocytes through an attenuation
of JNK-mediated PPARg suppression.12 More recently,
it was reported that HT has an anti-adipogenic effect
on 3T3-L1 cell differentiation by down-regulating cell
proliferation and cannabinoid receptor (CB1) gene
expression.13
In the present research we analyzed, the effects of HT
on primary omental pre-adipocyte and adipocyte via-
bility, apoptosis, adipogenesis, and lipolysis. Furthermore,
the expression level of genes involved in pathways
affecting the process of human adipogenesis and fat stor-
age were identified and validated using RT2 Profiler PCR
array.
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Material and methods
Materials
3-Hydroxytyrosol, (3,4-dihydroxyphenyl ethanol) was pur-
chased from Sigma (cat. n. H4291 Milan, Italy) with a purity
of 98% (HPLC) and kept in dark at 4C until further use.
Stock solution of 3-Hydroxytyrosol was prepared in 1 ml of
10% dimethylsulfoxide (DMSO), filtered through 0.22-mm
pore size nylon membrane (Millipore, Milan, Italy) and
kept in dark at 20C until further analysis.
Cell culture and treatment
Human omental pre-adipocyte cells and medium were
obtained from ZenBio (USA). According to the data
kindly provided by ZenBio, pre-adipocyte cells (OP-F-3)
were collected from Caucasian, non-diabetic, and non-
smoking female donors (n¼ 3) with the mean age of
48.7 9.1 years and the mean BMI of 42.7 6.9 kg/cm2.
Visceral pre-adipocytes were plated and proliferated in
Omental Preadipocyte Medium (OM-PM) till the passage 3.
All the experiments were run in the humidified 37C incu-
bator with 5% CO2. OM-PM was changed each second day
till the cells reached full confluence. At this moment, OM-
PM was completely removed, cells were washed with phos-
phate-buffered saline (PBS 1) and fed with Omental
Differentiation Medium (OM-DM) and further with
Omental Adipocyte Medium (OM-AM) added with HT at
a concentration of 5, 10, 30, and 70mg/mL with final con-
centration of 0.0014% DMSO. The control cells (CTRL) were
incubated in OM-DM and OM-AM without HT in the pre-
sent of 0.0014% DMSO as well.
HT treatment was performed from the first day of dif-
ferentiation till 10 days in OM-DM (P10), till 20 days in
OM-DM (P20) and during seven days post differentiation
in OM-AM (A7). Cells were analyzed at the end of each
differentiation period.
Apoptosis, lipolysis, and adipogenesis assays were per-
formed in a 96-well plate with the cell density of 104 cells/
well, while PCR assay was performed in a 6-well plate with
the cell density of 105 cells/well.
All analyses were performed using cells of three dif-
ferent donors and each donor was assayed in triplicate.
Cell viability
The cytotoxicity of HT at different concentrations (5, 10,
30, and 70 mg/mL) was measured by the 3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide
(MTT) colorimetric assay. At the end of each differenti-
ation period (P10, P20, A7), cells were washed with
PBS 1X, added with MTT solution (5 mg/ml in fresh
medium) and incubated for 3 h at 37C. Then, the mixture
was carefully removed from each well followed by add-
ition of 100mL of DMSO. Absorbance was read with a
microplate reader at 570 nm. The percentage of viable
cells was calculated by normalizing the absorbance
value of the treated cells by the absorbance value of the
CTRL cells.
Apoptosis assay
Apoptosis determination in P10, P20, A7 HT-treated cells
(30mg/mL), and CTRL cells was performed using
ApoStrandTM ELISA apoptosis detection kit (Enzo Life
Sciences Inc., NY, USA) according to provider’s instruc-
tions.7 The apoptotic positive control (single stranded
DNA in PBS) was also included in the analysis. Data are
expressed as the percentage of cells, comparing the optical
density of the treated/CTRL cells with the optical density of
the positive CTRL.
Oil Red O staining and measurement
of lipid accumulation
Intracellular lipid accumulation in P10 and P20 HT-treated
and CTRL cells was analyzed by microscopy after staining
cells with Oil red O (ORO, Sigma, Milan, Italy), and quan-
tification using a spectrophotometer at 520 nm. Data are
expressed as percentage of lipid accumulation relative to
the control samples.
Lipolysis assay
Detection of the lipolytic activity in HT-treated P20 and
A7 cells was performed using AdipoLyzeTM Lipolysis
Detection Kit (Lonza Walkersville Inc., MD, USA), based
on the quantification of the glycerol release by cells
undergoing lipolysis.7 Accumulated glycerol in each
sample was determined by comparison with a glycerol
standard curve.
RNA extraction and adipogenesis PCR array
Prior to the total RNA extraction, HT-treated P20 and CTRL
cells were rinsed with ice-cold PBS followed by the RNA
extraction with miRNeasy kit and QIAzol Lysis Reagent
(Qiagen, Milan, Italy) according to the manufacturer’s rec-
ommendations. Synthesis of the first strand cDNA was per-
formed using RT2 First Strand kit (Qiagen, Milan, Italy).8
The gene expression profile of adipogenesis was deter-
mined using ready to use human Adipogenesis RT2 Profiler
PCR array (PAHS-049Z; Qiagen, Milan, Italy) containing
primers for 84 tested, five housekeeping genes and controls
for RT and PCR reactions. The expression of target genes
was normalized andCts were calculated by the difference
between Ct of target genes and the geometric mean of the
four housekeeping genes. Differences between HT samples
and CTRL were calculated using the 2Ct method,14,15
where 2Ct represents the difference of a given target
gene in HT-treated cells versus CTRL. The n-fold expression
of a given target gene was calculated as log2(2
Ct).
Statistical analysis
In the cell viability assay, differences between HT-treated
cells were determined by one-way ANOVA with HT con-
centration (4 levels) as fixed factor.16 Significant effects of
the HT treatment on cell apoptosis, triglyceride accumula-
tion, and lipolysis were assessed with two-way ANOVA16
considering the fixed effect of treatment (HT-treated and
CTRL cells) and the fixed effect of period of differentiation
(for apoptosis and lipolysis assay: P20 and A7 cells; for lipid
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accumulation assay: P10 and P20 cells). The effect of inter-
action (treatment x period of differentiation) was tested in
two-way ANOVA as well.
PCR array data, expressed as log2(n-fold), were analyzed
using one sample T test.16 Results are displayed in a form of
a volcano plot, which graphically shows the relationships
between fold-change estimates and statistical significance
values, reported as the negative log10(P value). The horizon-
tal red line on the plot indicates a significance cutoff of
P¼ 0.05.
Results
Cell viability
The cell viability assay was performed to determine the
highest dose of HT that did not reduce the cell viability
for more than 40% compared to CTRL cells. Treatment of
P10 and P20 cells with 5, 10, 30, and 70 mg/mL of HT
showed a significant (P< 0.001) decrease in cell viability
in a dose-dependent manner (Table 1). Cell viability of
P10 and P20 remained over 70% with HT concentration
till 30 mg/mL and dramatically decreased (P< 0.001) at a
concentration of 70 mg/mL. On the contrary, HT treatment
of A7 cells did not influence so much the cell viability. For
A7, cell viability remained over 90% even at the concentra-
tion of 70 mg/mL. According to these observations and in
accordance with Drira et al.,17 the HT concentration of
30mg/mL was chosen for the further experiments.
Effect of HT on apoptosis
The apoptotic effect of the HT was examined on P10, P20,
and A7 cells treated with 30 mg/mL of HT and on corres-
ponding CTRL cells. The results are reported as the percent-
age of apoptotic cells, calculated as the ratio of apoptotic
positive cells, provided by the commercial ELISA kit, and of
the treated/CTRL cells (Figure 1). The percentage of apop-
tosis induced by HT extract was significantly (P< 0.001)
higher in P10 and P20 cells respect to CTRL cells (48.5
2.5% vs. 19.7 8.7% and 48.4 0.8% vs. 20.3 2.5%,
respectively). Conversely, in A7 cells, the percentage of
apoptosis did not significantly vary between treated and
CTRL cells. The interaction between effect of treatment
(HT-treated and CTRL cells) and effect of period of differ-
entiation (P10, P20 and A7) showed high significance
(P< 0.001).
HT decreases triglyceride accumulation
According to the results of the apoptosis assay, P10 and P20
cells were significantly affected by HT treatment and dif-
fered from the mature adipocytes (A7). To evaluate the abil-
ity of HT to affect adipogenesis through the prevention of
the triglyceride accumulation in differentiating pre-adipo-
cytes, the total amount of lipid accumulation in HT-treated
P10 and P20 cells respect to untreated CTRL cells was
reported (Figure 2). These data indicate that HT treatment
inhibits adipogenesis of differentiating P10 and P20 cells,
Figure 1 Modulation of apoptosis by HT in human omental pre-adipocytes. Cells were treated with 30 mg/mL HT extract. P10, differentiating pre-adipocytes treated
for 10 days; P20, differentiating pre-adipocytes treated for 20 days; A7, mature adipocytes treated for 7 days. Data are reported as the percentage of apoptotic cells in
HT-treated/CTRL cells vs positive CTRL. Data are mean standard deviation (SD). Asterisks on the plain line indicate the significant difference between treatments,
P< 0.001. Asterisks on the dotted line indicate the significant difference between different differentiation periods (P10, P20, A7), P<0.001
Table 1 Modulation of MTT metabolism by HT in human omental
pre-adipocytes. Cells were treated with 5, 10, 30, and 70mg/mL HT
Dose (kg/ml) P10 P20 A7
5 90.25A 7.42 92.95A 2.97 97.97A 2.02
10 74.39B6.97 79.50B2.75 96.13A 2.39
30 71.16B7.82 70.68C2.86 95.02A 2.44
70 48.13C4.46 45.72D1.88 90.97B2.00
HT: hydroxytyrosol.
Note: P10 differentiating pre-adipocytes treated for 10 days; P20 differentiating
pre-adipocytes treated for 20 days; A7, mature adipocytes treated for 7 days.
Data are means standard deviation (SD). Different superscript capital letters
indicate significantly differences (P<0.001) within treatments at different
concentrations.
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decreasing significantly (P< 0.001) the level of triglycer-
ides. The percentage of triglyceride accumulation in HT-
treated cells (P10 and P20) respect to CTRL cells was sig-
nificantly (P< 0.001) lower (100.119.6% in P10 cells P10
and 100.5 8.1% in P20 cells). The percentage of triglycer-
ide accumulation in HT-treated P20 cells was significantly
(P< 0.001) lower respect to HT-treated P10 cells
(51.110.2% in P10 cells and 22.1 3.4% in P20 cells). The
interaction between the effect of treatment (HT-treated and
CTRL cells) and the effect of period of differentiation (P10,
P20) was significant (P< 0.001) as well.
HT treatment increases glycerol release
To determine whether HT treatment affected lipolytic
responsiveness of cells, we measured glycerol release in
P20 pre-adipocytes and in mature adipocytes (A7). HT-trea-
ted P20 pre-adipocytes were chosen as at this stage of dif-
ferentiation cells are not fully mature but still in active
development and at the same time already reached the
reduction of TG in comparison to HT-treated P10 cells.
The effect of HT treatment on glycerol release in A7 adipo-
cytes was performed as these cells were considered fully
mature, showed rounded shape, and contained large lipid
droplets in the cytoplasm (data not shown).
Respect to CTRL cells, an HT-induced increase
(P< 0.001) of free glycerol in the culture medium was
observed both in P20 (93.2 mM 4.0 in CTRL and
199.5mM 36.1 in P20 cells) and A7 cells (2.5 mM 0.6 in
CTRL cells and 153.8 mM 73.7 in A7 cells) (Figure 3). The
interaction between effect of treatment and period of differ-
entiation in this analysis was not significant.
Figure 2 Effect of HT (30 mg/mL) on triglyceride accumulation during pre-adipocyte differentiation. Data are expressed as percentage of triglyceride accumulation in
differentiating HT-treated pre-adipocytes (P10 and P20) relative to the control cells. Results are depicted as mean standard deviation (SD). Asterisks indicate the
significant difference between treatments for P< 0.001
Figure 3 Detection of the lipolytic activity in differentiating and mature adipocytes after HT treatment (30mg/mL). Glycerol release was measured after 20 days (P20)
of treatment during pre-adipocytes differentiation and after seven days of treatment of already mature cells (A7). Accumulated glycerol in each sample was determined
by comparison with a glycerol standard curve. Glycerol content is expressed in mM and depicted as mean standard deviation (SD). Asterisks indicate the significant
difference between treatments for P< 0.001
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Effects of HT treatment on the adipogenesis-related
gene expression
According to the results of the apoptosis, adipogenesis and
lipolysis assays, P20 cells, as the most responsive to the HT
treatment, were chosen for the determination of the expres-
sion pattern of genes involved in the adipogenesis path-
ways. RT2 Profiler PCR array data are reported in a form
of a volcano plot as log2(n-fold) values of significantly
(P< 0.05) up- and down-regulated genes in comparison to
CTRL cells (Figure 4). The results revealed that HT treat-
ment at a dose of 30 mg/mL significantly (P< 0.05) up-
regulated the expression of 19.0% (16/84) of genes and
down-regulated the expression of 4.7% (4/84) of genes
involved in adipogenesis pathways (Figure 4; SM Table 1).
Among the significantly (P< 0.05) up-regulated genes
that inhibited adipogenesis in P20 HT-treated cells are
ADRB2, DDIT3, GATA2, GATA3, HES1, LPL, PPARGC1A,
PRDM16, SIRT1, SFRP5, WNT1, and WNT3A. Four signifi-
cantly (P< 0.05) down-regulated genes in P20 HT-treated
cells included CCND1, FGF1, LEP, and SREBF1.
Discussion
The present study aimed to characterize the effects of HT,
known as an antioxidant phenolic olive-derived compound
typically present in the virgin olive oil, on human visceral
pre-adipocytes differentiation, lipolysis, and apoptosis.
The significant decrease in triglyceride accumulation by
HT treatment (Figure 2) is in accordance with the results
obtained on the 3T3-L1 cells treated with five times
more concentrated HT.17 Drira et al.17 proposed that the
anti-adipogenic activity of HT at early stage of cell differen-
tiation is due to a delay in the cell cycle progression and to a
down-regulation of the SREBP-1c expression. Our data
demonstrated that SREBF1 (also known as SREBP-1c) and
CCND1 are among the down-regulated genes in HT-treated
P20 cells (Figure 4 and SM Table 1), suggesting the same
involvement in the cycle arrest and attenuated lipogenic
activity. Interestingly, HT treatment on P20 cells signifi-
cantly reduced the expression of FGF1, which in turn is
related to CCND1 via ERK signaling.
It was previously reported18 that the high-fat diet, sup-
plemented with the analogues antioxidant olive-derived
molecule known as oleuropein, decreases mRNA levels of
FGF1-mediated signaling molecules in liver of mice.
Drira and Sakamoto19 showed that HT treatment of 3T3-
L1 cells stimulated glycerol release in addition to the
increased rate of HSL and perilipin phosphorylation via
PKA and also through ERK phosphorylation.
It is known that catecholamines may influence both PKA
and ERK pathways to induce lipolysis20 through the activa-
tion of b-adrenoceptors. Although we did not measure the
downstream activation of HSL nor ERK phosphorylation
followed by HT treatment of P20 cells, a significant increase
of adrenoceptor beta 2 (ADRB2) expression was observed
(Figure 4 and SM Table 1). This observation is matching well
with the fact that ADRB2 expression in adipose tissue is
conversely down-regulated in obese subjects.21
Of note, a significant ADRB2 up-regulation could
contribute to the enhanced lipolysis observed in 3T3-L1
cells by an increase of autolysosome-targeted lipid
droplets.22
Figure 4 Volcano plot of significantly (P<0.05) up- and down-regulated genes in HT-treated (30mg/mL) P20 cells in comparison to untreated P20 CTRL cells. Human
RT2 Profiler PCR array data are reported as log2(n-fold) values plotted against negative Log10(P value). Red indicator¼ significantly up-regulated gene; Green
indicator¼ significantly down-regulated gene. Red line¼ indicates Log10(P value), P< 0.05. (A color version of this figure is available in the online journal.)
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Interestingly, HT treatment effectively (P< 0.001)
induced apoptosis only in P20 cells, whereas the treatment
of A7 adipocytes did not lead to any difference in compari-
son to CRTL cells (Figure 1). Similar results were obtained
previously with Rosmarinus officinalis7 and Rhodiola rosea8
extracts. The apoptotic effect of HT, through the G0/G1
phase arrest and a concomitant decrease of cells in the S
and G2/M phases, was already demonstrated in different
cell lines, including human colon cancer cells23 and MCF-7
human breast cancer cells.24
As already evidenced, different biological compounds
affect adipogenesis through the wingless-type (WNT) sig-
naling.8,25 In the present study, a significant (P< 0.05)
increase of canonical expression of WNTS, such as
WNT1,WNT3A, and WNT pathway inhibitor gene SFRP5,
was observed.26 The significantly decreased expression of
CCND1, a downstream target gene of b-catenin,27 can be
also related to the up-regulation of SFRP5 (Figure 4), which
prevents activation of frizzled receptors and in this way
attenuating the non-canonical WNT signaling.28
SIRT1 gene is known to reduce fat synthesis and fat cell
differentiation29 and to improve free fatty acid release from
fat cells.30 Its up-regulation (P< 0.05) in HT-treated
P20 cells is consistent with the down-regulation of PPARG
(although not significantly modulated; SM Table 1)
and with the significantly enhanced cell lipolysis.
Previously it was already reported that PPARG expression
is down-regulated by SIRT1 in 3T3-L1 adipocytes.30
Moreover, HT has recently been shown to up-regulate the
SIRT1 gene expression in the heart tissue of senescence-
accelerated mouse.31
Two isoforms, GATA-2 and GATA-3, are specifically
expressed in pre-adipocytes and down-regulated in
mature adipocytes32 and it was suggested that GATAs
activity is mediated through reduced PPARG promoter
activity.33 In the present study, GATA-2 was significantly
(P< 0.05) up-regulated in HT-treated P20 cells in compari-
son to CTRL cells and this is coherent with an inhibitory
effect on adipogenesis, observed in P20 cells treated with
1% salidroside plus 3% rosavines.8
The over-expression of HES1 (P< 0.05) in HT-treated P20
cells can be related to a reduction of intracellular lipid accu-
mulation. It was found by several research groups that
HES1 transcription factor is down-regulated during adipo-
genesis in vitro and in vivo,34 inhibiting the early phase of
adipogenesis in 3T3-L1 cells35 and porcine mesenchymal
stem cells.36
Expression of PPARGC1A, a major regulator of mito-
chondrial biogenesis and an activator of mRNA expression
of uncoupling protein 1 (UCP1) in white adipocytes, were
up-regulated by HT treatment in P20 cells (Figure 4 and SM
Table 1). The same conclusions were reached by Hao et al.37
at lower HT concentration and 3T3L1 cells. PPARGC1A was
found to be activated also by grape skin and seed extracts,
that are rich in antioxidant phenolic compounds.38
PRDM16, bounded by PPARGC1A, was also positively
regulated in HT-treated P20 cells and its expression has
also been shown to protect against weight gain on high-
fat diets.39
Expression of genes involved in adipocyte function and
development, such as LEP, were significantly (P< 0.05)
decreased during differentiation of pre-adipocytes in the
presence of HT extract.
Conclusions
In conclusion, we have demonstrated that HT extract
induced apoptosis in differentiating pre-adipocytes (P10
and P20), but not in mature adipocytes (A7). HT extract
inhibited differentiation of visceral pre-adipocytes and pro-
moted lipolytic activity in pre-adipocytes as well as in
already mature adipocytes. Molecular analysis showed
that HT treatment modulated the expression of several
genes associated with adipogenesis.
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